Trials / Completed
CompletedNCT00210288
Healthy Adult Volunteer Study for Two Doses of a Shigella Vaccine
A Comparative Double Blind Placebo-Controlled Study of Immunogenicity and Safety of Two Doses 10^5 and 10^7 CFU of SC599 Oral Vaccine, a Live Attenuated Shigella Dysenteriae 1 Vaccine Strain in Healthy Human Adult Volunteers
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 111 (estimated)
- Sponsor
- Institut Pasteur · Industry
- Sex
- All
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to assess the immune response produced by two doses of SC599 vaccine compared to placebo.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | SC599 |
Timeline
- Start date
- 2005-05-01
- Primary completion
- 2006-09-01
- Completion
- 2007-04-01
- First posted
- 2005-09-21
- Last updated
- 2018-08-08
Locations
2 sites across 2 countries: France, United Kingdom
Source: ClinicalTrials.gov record NCT00210288. Inclusion in this directory is not an endorsement.